Dengue IgG/IgM & NS1 Antigen Combo Rapid Test Device - India CDSCO Medical Device Registration

Dengue IgG/IgM & NS1 Antigen Combo Rapid Test Device is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000016_b46dca261b1323ee34ce5789adbb1e6a_513033bec385e7620c80225770660347. This device is marketed under the brand name CRP. The license holder is BIOLINE DIAGNOSTICS LLP, and it is classified as Device Class Class C. The approving authority is CDSCO -North Zone, Ghaziabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

Dengue IgG/IgM & NS1 Antigen Combo Rapid Test Device

UID: MFG/IVD/2020/000016_b46dca261b1323ee34ce5789adbb1e6a_513033bec385e7620c80225770660347

Brand Name

CRP

License Holder

BIOLINE DIAGNOSTICS LLP

Device Class

Class C

Approving Authority

CDSCO -North Zone, Ghaziabad

Product Information

Dengue IgG/IgM & NS1 Antigen Combo Rapid Test Device is an in vitro qualitative immunochromatographic assay for the rapid detection of Dengue NS1 antigens and anti-dengue IgG/IgM antibodies in human blood, serum and plasma specimens simultaneously

Class B

G-6PDH

Brand: CRP

DELTA LAB

Class B

Brand: First View

Class D